← Back to Patent Explorer
US4752645A Expired / Lapsed US ⏱️ 0.0 years remaining

Benzazepine derivatives

Assignee: ER Squibb and Sons LLC
•
Filing: 1987-05-21
•
Granted: 1988-06-21
•
Expires: 2007-05-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Vasodilating activity is exhibited by compounds having the formula ##STR1## and pharmaceutically acceptable salts thereof.

Inventors

  • 👤 Jagabandhu Das
  • 👤 David Floyd
  • 👤 John Krapcho

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 17:21
CPC Classifications
C; C07; C07D; C07D223/00; C07D223/14; C07D223/16; A; A61; A61P; A61P11/00; A61P9/00; A61P9/06; A61P9/08; A61P9/10; A61P9/12

Claims Analysis

Total Claims: 42
Claim 1
Independent Claim 323 words
A compound having the formula ##STR20## or a pharmaceutically acceptable salt thereof wherein R and R 1 are each hydrogen or alkyl, R is hydrogen and R 1 is alkenyl, alkynyl, aryl, heteroaryl or cycloalkyl, or R and R 1 together with the carbon atom to which they are attached are cycloalkyl; R 2 and R 3 are each independently hydrogen, alkyl, cycloalkyl, or arylalkyl or R 2 and R 3 together with the nitrogen atom to which they are attached are pyrrolidinyl, piperidinyl, or morpholinyl; R 4 and R 5 are each independently hydrogen, halogen, alkyl, alkoxy, aryloxy, arylalkoxy, arylalkyl, hydroxy, alkanoyloxy, ##STR21## difluoromethoxy, trifluoromethyl, --NX 3 X 4 , --SO m alkyl, or --SO m aryl; n is 2 or 3; m is 0, 1 or 2; X 1 and X 2 are each independently hydrogen, alkyl, aryl or heteroaryl, or X 1 and X 2 together with the nitrogen atom to which they are attached are a nitrogen containing heteroaryl; X 3 and X 4 are each independently hydrogen, alkyl, alkanoyl, arylcarbonyl, heteroarylcarbonyl, carbamoyl, alkylsulfonyl, or arylsulfonyl; with the proviso that if R 4 is a 7-alkyl group, it must have a tertiary carbon atom bonded to the ring; wherein the term "aryl" refers to phenyl and phenyl substituted with 1, 2 or 3 amino, alkylamino, dialkylamino, nitro, halogen, hydroxyl, trifluoromethyl, alkyl or 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkanoyloxy carbamoyl, or carboxyl groups; the term "heteroaryl" refers to pyridinyl, pyrrolyl, imidazolyl, furyl, thienyl, or thiazolyl; the term "nitrogen containing heteroaryl" refers to pyridinyl, pyrrolyl, imidazolyl and thiazolyl; the terms "alkyl" and "alkoxy" refer to groups having 1 to 10 carbon atoms; the terms "alkenyl" and "alkynyl" refer to groups having 2 to 10 carbon atoms; the term "alkanoyl" refers to groups having 2 to 11 carbon atoms; and the term "cycloalkyl" refers to groups having 3, 4 5, 6 or 7 carbon atoms.
Claim 2
Dependent Claim 323 words
A compound having the formula ##STR20## or a pharmaceutically acceptable salt thereof wherein R and R 1 are each hydrogen or alkyl, R is hydrogen and R 1 is alkenyl, alkynyl, aryl, heteroaryl or cycloalkyl, or R and R 1 together with the carbon atom to which they are attached are cycloalkyl; R 2 and R 3 are each independently hydrogen, alkyl, cycloalkyl, or arylalkyl or R 2 and R 3 together with the nitrogen atom to which they are attached are pyrrolidinyl, piperidinyl, or morpholinyl; R 4 and R 5 are each independently hydrogen, halogen, alkyl, alkoxy, aryloxy, arylalkoxy, arylalkyl, hydroxy, alkanoyloxy, ##STR21## difluoromethoxy, trifluoromethyl, --NX 3 X 4 , --SO m alkyl, or --SO m aryl; n is 2 or 3; m is 0, 1 or 2; X 1 and X 2 are each independently hydrogen, alkyl, aryl or heteroaryl, or X 1 and X 2 together with the nitrogen atom to which they are attached are a nitrogen containing heteroaryl; X 3 and X 4 are each independently hydrogen, alkyl, alkanoyl, arylcarbonyl, heteroarylcarbonyl, carbamoyl, alkylsulfonyl, or arylsulfonyl; with the proviso that if R 4 is a 7-alkyl group, it must have a tertiary carbon atom bonded to the ring; wherein the term "aryl" refers to phenyl and phenyl substituted with 1, 2 or 3 amino, alkylamino, dialkylamino, nitro, halogen, hydroxyl, trifluoromethyl, alkyl or 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkanoyloxy carbamoyl, or carboxyl groups; the term "heteroaryl" refers to pyridinyl, pyrrolyl, imidazolyl, furyl, thienyl, or thiazolyl; the term "nitrogen containing heteroaryl" refers to pyridinyl, pyrrolyl, imidazolyl and thiazolyl; the terms "alkyl" and "alkoxy" refer to groups having 1 to 10 carbon atoms; the terms "alkenyl" and "alkynyl" refer to groups having 2 to 10 carbon atoms; the term "alkanoyl" refers to groups having 2 to 11 carbon atoms; and the term "cycloalkyl" refers to groups having 3, 4 5, 6 or 7 carbon atoms.
Claim 3
Dependent Claim 56 words
A compound in accordance with claim 1 wherein R 2 and R 3 are each independently alkyl or cycloalkyl or R 2 and R 3 together with the nitrogen atom to which they are attached are pyrrolidinyl, piperidinyl or morpholinyl; and X 3 and X 4 are each independently hydrogen, alkyl, alkanoyl, arylcarbonyl, heteroarylcarbonyl or carbamoyl.
Claim 4
Dependent Claim 14 words
A compound in accordance with claim 1 wherein R and R 1 are hydrogen.
Claim 5
Dependent Claim 24 words
A compound in accordance with claim 1 wherein R is hydrogen and R 1 is alkyl or R and R 1 are each alkyl.
Claim 6
Dependent Claim 16 words
A compound in accordance with claim 1 wherein R is hydrogen and R 1 is alkenyl.
Claim 7
Dependent Claim 16 words
A compound in accordnce with claim 5 wherein R is hydrogen and R 1 is vinyl.
Claim 8
Dependent Claim 16 words
A compound in accordance with claim 1 wherein R is hydrogen and R 1 is alkynyl.
Claim 9
Dependent Claim 16 words
A compound in accordance with claim 1 wherein R is hydrogen and R 1 is aryl.
Claim 10
Dependent Claim 16 words
A compound in accordance with claim 1 wherein R is hydrogen and R 1 is heteroaryl.
Claim 11
Dependent Claim 16 words
A compound in accordance with claim 1 wherein R is hydrogen and R 1 is cycloalkyl.
Claim 12
Dependent Claim 24 words
A compound in accordance with claim 1 wherein R and R 1 together with the carbon atom to which they are attached are cycloalkyl.
Claim 13
Dependent Claim 19 words
A compound in accordance with claim 1 wherein at least one of R 2 and R 3 is hydrogen.
Claim 14
Dependent Claim 16 words
A compound in accordance with claim 1 wherein R 2 and R 3 are each alkyl.
Claim 15
Dependent Claim 16 words
A compound in accordance with claim 13 wherein R 2 and R 3 are each methyl.
Claim 16
Dependent Claim 16 words
A compound in accordance with claim 1 wherein R 2 and R 3 are each cycloalkyl.
Claim 17
Dependent Claim 16 words
A compound in accordance with claim 1 wherein R 2 and R 3 are each arylalkyl.
Claim 18
Dependent Claim 28 words
A compound in accordance with claim 1 wherein R 2 and R 3 together with the nitrogen atom to which they are attached are pyrrolidinyl, piperidinyl or morpholinyl.
Claim 19
Dependent Claim 12 words
A compound in accordance with claim 1 wherein R 4 is hydrogen.
Claim 20
Dependent Claim 14 words
A compound in accordance with claim 1 wherein R 4 is halogen or trifluoromethyl.
Claim 21
Dependent Claim 24 words
A compound in accordance with claim 19 wherein R 4 is chlorine or trifluoromethyl and is located in the 7-position of the benzazepine nucleus.
Claim 22
Dependent Claim 12 words
A compound in accordance with claim 1 wherein R 5 is alkoxy.
Claim 23
Dependent Claim 27 words
A compound in accordance with claim 1 wherein R 5 is methoxy and is located in the 4-position of the phenyl ring to which it is attached.
Claim 24
Dependent Claim 11 words
A compound in accordance with claim 1 wherein n is 2.
Claim 25
Dependent Claim 11 words
A compound in accordance with claim 1 wherein n is 3.
Claim 26
Dependent Claim 9 words
The d-cis enantiomer of a compound of claim 1.
Claim 27
Dependent Claim 14 words
The compound in accordance with claim 1, (cis)-7-chloro-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-methyl-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 28
Dependent Claim 14 words
The compound in accordance with claim 1, (cis)-7-chloro-1-[2-(dimethylamino)ethyl]-3-ethyl-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 29
Dependent Claim 14 words
The compound in accordance with claim 1, (cis)-7-chloro-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-(2-propenyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 30
Dependent Claim 14 words
The compound in accordance with claim 1, (cis)-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-methyl-7-(trifluoromethyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 31
Dependent Claim 14 words
The compound in accordance with claim 1, (cis)-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-(2-propenyl)-7-trifluoromethyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 32
Dependent Claim 14 words
The compound in accordance with claim 1, (cis)-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-propyl-7-(trifluoromethyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 33
Dependent Claim 14 words
The compound in accordance with claim 1, (cis)-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-(2-propenyl)-6-(trifluoromethyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 34
Dependent Claim 14 words
The compound in accordance with claim 1, (cis)-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-propyl-6-(trifluoromethyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 35
Dependent Claim 14 words
The compound in accordance with claim 25, (d-cis)-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-(2-propenyl)-6-(trifluoromethyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 36
Dependent Claim 14 words
The compound in accordance with claim 25, (d-cis)-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-ethyl-6-(trifluoromethyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 37
Dependent Claim 14 words
The compound in accordance with claim 25, (d-cis)-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-methyl-6-(trifluoromethyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 38
Dependent Claim 14 words
The compound in accordance with claim 1, (cis)-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-methyl-1-[2-[methyl(phenylmethyl)amino]ethyl-6-(trifluoromethyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 39
Dependent Claim 14 words
The compound in accordance with claim 1, (cis)-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-methyl-1-[2-(methylamino)ethyl]-6-(trifluoromethyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 40
Dependent Claim 14 words
The compound in accordance with claim 1, (cis)-1-[2-(diisopropylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-methyl-6-trifluoromethyl)-2H-1-benzazepin-2-one or a pharmaceutically acceptable salt thereof.
Claim 41
Dependent Claim 260 words
The d-cis enantiomer of a compound having the formula ##STR22## wherein R and R 1 are each hydrogen or alkyl, R is hydrogen and R 1 is alkenyl, alkynyl, aryl, heteroaryl or cycloalkyl, or R and R 1 together with the carbon atom to which they are attached are cycloalkyl; R 4 and R 5 are each independently hydrogen, halogen, alkyl, alkoxy, aryloxy, arylalkoxy, arylakyl, hydroxy, alkanoyloxy, ##STR23## difluoromethoxy, trifluoromethyl, --NX 3 X 4 , --SO m alkyl, or --SO m aryl; m is 0, 1 or 2; X 1 and X 2 are each independently hydrogen, alkyl, aryl or heteroaryl, or X 1 and X 2 together with the nitrogen atom to which they are attached are a nitrogen containing heteroaryl; X 3 and X 4 are each independently hydrogen, alkyl, alkanoyl, arylcarbonyl, heteroarylcarbonyl, carbamoyl, alkylsulfonyl, or arylsulfonyl; wherein the term "aryl" refers to phenyl and phenyl substituted with 1, 2 or 3 amino, alkylamino, dialkylamino, nitro, halogen, hydroxyl, trifluoromethyl, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkanoyloxy, carbamoyl, or carboxyl groups; the term "heteroaryl" refers to pyridinyl, pyrrolyl, imidazolyl, furyl, thienyl, or thiazolyl; the term "nitrogen containing heteroaryl" refers to pyridinyl, pyrrolyl, imidazolyl and thiazolyl; the terms "alkyl" and "alkoxy" refer to groups having 1 to 10 carbon atoms; the terms "alkenyl" and "alkynyl" refer to groups having 2 to 10 carbon atoms; the term "alkanoyl" refers to groups having 2 to 11 carbon atoms; and the term "cycloalkyl" refers to groups having 3, 4, 5, 6 or 7 carbon atoms.
Claim 42
Dependent Claim 260 words
The d-cis enantiomer of a compound having the formula ##STR22## wherein R and R 1 are each hydrogen or alkyl, R is hydrogen and R 1 is alkenyl, alkynyl, aryl, heteroaryl or cycloalkyl, or R and R 1 together with the carbon atom to which they are attached are cycloalkyl; R 4 and R 5 are each independently hydrogen, halogen, alkyl, alkoxy, aryloxy, arylalkoxy, arylakyl, hydroxy, alkanoyloxy, ##STR23## difluoromethoxy, trifluoromethyl, --NX 3 X 4 , --SO m alkyl, or --SO m aryl; m is 0, 1 or 2; X 1 and X 2 are each independently hydrogen, alkyl, aryl or heteroaryl, or X 1 and X 2 together with the nitrogen atom to which they are attached are a nitrogen containing heteroaryl; X 3 and X 4 are each independently hydrogen, alkyl, alkanoyl, arylcarbonyl, heteroarylcarbonyl, carbamoyl, alkylsulfonyl, or arylsulfonyl; wherein the term "aryl" refers to phenyl and phenyl substituted with 1, 2 or 3 amino, alkylamino, dialkylamino, nitro, halogen, hydroxyl, trifluoromethyl, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkanoyloxy, carbamoyl, or carboxyl groups; the term "heteroaryl" refers to pyridinyl, pyrrolyl, imidazolyl, furyl, thienyl, or thiazolyl; the term "nitrogen containing heteroaryl" refers to pyridinyl, pyrrolyl, imidazolyl and thiazolyl; the terms "alkyl" and "alkoxy" refer to groups having 1 to 10 carbon atoms; the terms "alkenyl" and "alkynyl" refer to groups having 2 to 10 carbon atoms; the term "alkanoyl" refers to groups having 2 to 11 carbon atoms; and the term "cycloalkyl" refers to groups having 3, 4, 5, 6 or 7 carbon atoms.

References Cited (Backward Citations)

US3075967A Cited
US3312691A Cited
US3330823A Cited
US3748321A Cited
US3562257A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-06-21 1991-12-21 1992-06-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-06-21 1995-12-21 1996-06-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-06-21 1999-12-21 2000-06-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag